TELA.O (TELA.O) News
Follow TELA.O (TELA.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026
TELA Bio entered a limited consent with Perceptive Credit Holdings V and required lenders to suspend testing of its minimum revenue covenant for quarters ending around Sept. 30, 2026, and Dec. 31, 2026.
EQUITY | Sep 29, 2026, 08:09 PM UTC
L
TELA Bio director Joseph H. Capper acquires common shares worth USD 88,845.00
TELA Bio director Joseph H Capper bought 75,000 common shares in open-market purchases. Average purchase prices were USD 1.17 per share, USD 1.22 per share. Directly owned stake rose to 179,827 common shares. Disclaimer:
REGULATION | Sep 18, 2026, 08:32 PM UTC
L
TELA Bio faces Nasdaq delisting notice after failing $1 minimum bid rule
TELA Bio received a Nasdaq delisting notice tied to the $1 minimum bid rule, following a 180-day compliance deadline that ended Sept. 14, 2026. Nasdaq warned on Sept. 15, 2026 that the shares face delisting unless the co
REGULATION | Sep 18, 2026, 08:07 PM UTC